Read more

December 30, 2019
1 min read
Save

Raindrop inlay recall tops 2019’s refractive news

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Early in 2019, the FDA issued a notice of recall for all lots of the Raindrop near vision inlay. The alert was the most-read refractive-based story on Healio.com/OSN this past year.

Here are 2019’s top five refractive articles and videos:

 

Raindrop near vision inlay recalled

A safety communication from the FDA issued in October 2018 recommended the Raindrop inlay stop being implanted after a post-approval study found 75% of patients experienced corneal haze. Read more.

 

Yellow lens glasses do not improve night driving

A single-center cohort study of 22 individuals who underwent eight night driving scenarios using a driving simulator and a custom headlight glare simulator aimed to test the validity of yellow lens glasses, which have been marketed to improve night driving visibility and filter out headlight glare. Read more.

 

VIDEO: J&J Vision launches Tecnis Synergy IOL, preloaded injectors

PARIS — At the European Society of Cataract and Refractive Surgeons meeting, Tom Frinzi, worldwide president of surgical, Johnson & Johnson Vision, speaks about newly launched products: Tecnis Synergy, a continuous range of vision IOL for presbyopia, and two preloaded injectors, one disposable and one reusable. Commitment to innovation is the core philosophy of the company, he says. Watch video.

 

Novel trifocal IOL yields positive intermediate, near visual acuity results

Compared with a monofocal IOL, a novel trifocal IOL provides similar distance vision and improved intermediate and near vision, according to a speaker at the American Society of Cataract and Refractive Surgery meeting. Read more.

 

FDA approves EyeGate PRK pivotal study

The company’s OBG platform, based on cross-linked thiolated carboxymethyl hyaluronic acid, helps with hydrating and healing the ocular surface. It is suited for ocular surface injuries because it adheres longer to the ocular surface, resists degradation and protects the ocular surface. Read more.